Advertisement

L’Endocrinologo

, Volume 9, Issue 2, pp 76–81 | Cite as

Farmaci interferenti sulla neuroregolazione

  • Bruno Ambrosi
  • Federica Ermetici
Commissione Farmaci della S.I.E. Interferenze farmacologiche sulla diagnostica ormonale dell’asse ipotalamo-ipofisi-surrene (HPA)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografia

  1. 1.
    Ur E, Grossman A. The neuroregulation of corticotropin secretion. The pituitary gland, 2nd ed., Raven Press, New York, 1994, pp. 309–330.Google Scholar
  2. 2.
    Holsboer F, Barden N. Antidepressant and Hypothalamic-Pituitary-Adrenocortical regulation. Endocr Rev 1996, 17: 187PubMedCrossRefGoogle Scholar
  3. 3.
    Arvat E, Giordano R, Grottoli S, Ghigo E. Benzodiazepines and anterior pituitary function. J Endocrinol Invest 25: 735, 2002.PubMedGoogle Scholar
  4. 4.
    Arvat E, Maccagno B, Ramunni J, Di Vito L, Giordano R, Gianotti L, Broglio F, Camanni F, Ghigo E. The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulated effect of metyraponeinduced lack of negative cortisol feedback on corticotroph secretion in humans. J Clin Endocrinol Metab 84: 2611, 1999.PubMedGoogle Scholar
  5. 5.
    Ambrosi B, Dall’Asta C, Cannavò S, Libè R, Vigo T, Epaminonda P, Chiodini I, Ferrero S, Trimarchi F, Arosio M, Beck-Peccoz P. Effects of chronic administration of PPAR-ligand rosiglitazone in Cushing’s disease. Eur J Endocrinol 151: 173, 2004.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2008

Authors and Affiliations

  1. 1.Dipartimento di Scienze Medico-Chirurgiche, U.O. di EndocrinologiaIRCCS PoliclinicoSan Donato Milanese (MI)Italia

Personalised recommendations